Faculty Information - 逸見　百江

（Last updated : 2025-05-01 18:23:15）

逸見　百江
Department Kawasaki Medical School Kawasaki Medical School, Department of Natural Sciences,

Position Instructor

■ Present specialized field

Molecular biology, Bacteriology, Virology, Immunology, Tumor biology, Laboratory animal science, Urology (Key Word：Immunity, Microbiology, Cell Adhesion, Oxidative Stress, Signal Transduction)

■ Journal

1.	2025/02	Experimental Murine Periodontitis Increases Salivary Gland IgA-Producing B Cells Following Oral Dysbiosis.
2.	2025/01	Inflammasome regulation by the cell surface ecto-5'-nucleotidase of the oral commensal, Streptococcus oralis.
3.	2025	Pathogenic effects of Streptococcus oralis intestinal colonization on bladder health in mice.
4.	2024/12	Efficacy of Cetylpyridinium Chloride Mouthwash on Denture Plaque Reduction and Microbiome Alteration in a Randomized Crossover Trial.
5.	2024/03	The Klebsiella mannose phosphotransferase system promotes proliferation and the production of extracellular polymeric substances from mannose, facilitating adaptation to the host environment.
6.	2023/03	Oral commensal bacterial flora is responsible for peripheral differentiation of neutrophils in the oral mucosa in the steady state.
7.	2022/10	Melatonin suppresses the antiviral immune response to EMCV infection through intracellular ATP deprivation caused by mitochondrial fragmentation.
8.	2022/07	Novel antibody assessment method for microbial compositional alteration in the oral cavity.
9.	2022/01	Coculture in vitro with endothelial cells induces cytarabine resistance of acute myeloid leukemia cells in a VEGF-A/VEGFR-2 signaling-independent manner.
10.	2021/10	The downregulation of NADPH oxidase Nox4 during hypoxia in hemangioendothelioma cells: a possible role of p22phox on Nox4 protein stability.
11.	2021/02	Profile of androgen receptor activators identified using high-throughput screen.
12.	2020/08	High-throughput screen identifies 5-HT receptor as a modulator of AR and a therapeutic target for prostate cancer.
13.	2019/11	Extracellular calcium stimulates osteogenic differentiation of human adipose-derived stem cells by enhancing bone morphogenetic protein-2 expression.
14.	2019/04	Mirabegron induces relaxant effects via cAMP signaling-dependent and -independent pathways in detrusor smooth muscle.
15.	2018/02	A20 restores phorbol ester-induced differentiation of THP-1 cells in the absence of nuclear factor-κB activation.
16.	2018/01	Overexpression of exchange protein directly activated by cAMP-1 (EPAC1) attenuates bladder cancer cell migration.
17.	2017/06	Glutathione Primes T Cell Metabolism for Inflammation.
18.	2016/07	Equol inhibits prostate cancer growth through degradation of androgen receptor by S-phase kinase-associated protein 2.
19.	2016/07	Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7.
20.	2016/01	Actions of cAMP on calcium sensitization in human detrusor smooth muscle contraction.
21.	2016	Epithelial to Mesenchymal Transition in Clear Cell Renal Cell Carcinoma with Rhabdoid Features.
22.	2015/12	Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
23.	2015/11	Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP(+)/NADPH ratio.
24.	2015/09	SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapy.
25.	2015/04/17	Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP(+)/NADPH ratio
26.	2015/03	Renal cancer treatment with recipient lymphocyte infusion enhanced the antitumor effect of nonmyeloablative allogeneic stem cell transplantation.
27.	2015/01	Autophagy-independent functions of UVRAG are essential for peripheral naive T-cell homeostasis.
28.	2014/08	PMA induces androgen receptor downregulation and cellular apoptosis in prostate cancer cells.
29.	2014/06	Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer.
30.	2014/06	Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer.
31.	2014/03	Largen: a molecular regulator of mammalian cell size control.
32.	2013/06	Human heterochromatin protein 1 isoforms regulate androgen receptor signaling in prostate cancer.
33.	2013/06	Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells.
34.	2013/05	Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15.
35.	2013/03	YB-1 suppression induces STAT3 proteolysis and sensitizes renal cancer to interferon-α.
36.	2012/09	D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function.
37.	2012/05	Downregulation of phosphodiesterase 4B (PDE4B) activates protein kinase A and contributes to the progression of prostate cancer.
38.	2012/05	Sunitinib enhances antitumor effects against chemotherapy-resistant bladder cancer through suppression of ERK1/2 phosphorylation.
39.	2011/07	Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells.
40.	2010/08	Sensitivity of doxorubicin-resistant cells to sorafenib: possible role for inhibition of eukaryotic initiation factor-2alpha phosphorylation.
41.	2010/02	Dual specificity phosphatase16 is a negative regulator of c-Jun NH2-terminal kinase activity in T cells.
42.	2010	Immunotherapy for renal cell carcinoma.
43.	2009/12	Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
44.	2009/07	IL-15 is critical for the maintenance and innate functions of self-specific CD8(+) T cells.
45.	2008/11	Identification of CD25+ gamma delta T cells as fetal thymus-derived naturally occurring IL-17 producers.
Display 5 items
Display all(45)